The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / UV Light from Nail Salon Dryers May Provoke Lupus Lesions

UV Light from Nail Salon Dryers May Provoke Lupus Lesions

November 4, 2021 • By Lisa Rapaport

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters Health)—Nail salon drying lamps that emit ultraviolet (UV) light may contribute to periungual cutaneous lupus erythematosus lesions, according to case reports detailed in a recent publication.1

You Might Also Like
  • Rheumatology Case Report: Bullous Lesions in Patient with Lupus
  • Rare Disease Sheds Light on the Origins of Lupus
  • Cutaneous Lupus Tied to Risk for Coexisting Autoimmune Conditions

Exposure to the sun has long been linked to exacerbations of skin lupus, and, more recently, other types of light sources including surgical lamps have been connected to cutaneous lupus flares, said senior study author Victoria Werth, MD, of the Department of Dermatology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia and the Corporal Michael J. Crescenz Veterans Affairs Medical Center.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The lamps used in salons to dry nails predominantly use UVA wavelengths,” Dr. Werth says by email. “UV A type 2 light UVA-2 is thought to be pathogenic in lupus.”

In a research letter published in Rheumatology, Dr. Werth and colleagues detail two case reports of patients who developed new periungual cutaneous lupus erythematosus (CLE) lesions after using nail salon drying lamps to help set gel manicures.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One patient was a 35-year-old female of South Asian descent who had a history of systemic lupus erythematosus (SLE) and discoid lupus erythematosus (DLE) diagnosed about 12 years earlier. Interventions for this patient included 250 mg of chloroquine three times per week, 0.6 mg colchicine daily, 3,000 mg of mycophenolate mofetil daily, and clobetasol 0.05% ointment.

This patient had experienced lupus manifestations including thrombocytopenia, leukopenia, photosensitivity, arthritis, and oral ulcers. She also had positivity for several serologies including ANA, dsDNA, SSA and RNP.

The second patient was a 40-year-old female of African American descent with a history of SLE and DLE who had been diagnosed about four years prior. This patient received treatments including 400 mg of hydroxychloroquine daily, 100 mg of azathioprine daily, 6 mg of methylprednisolone daily, and topical steroids including pimecrolimus 1% cream, triamcinolone 0.1% ointment, and clobetasol 0.05% ointment.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In the second patient, lupus manifestations included lymphopenia, proteinuria, arthritis of the wrists, hands, and feet. This woman had positivity for serologies including high-titer ANA 1:2560, and dsDNA antibody.

These women both had been getting manicures roughly every one-to-two months for several years.

The first patient started noticing lesions on her hands after about six months of regular gel manicures and reported a possible cumulative effect.

In the second patient, new erythema on her hands appeared roughly one week after getting a gel manicure.

Even though RNP antibodies can cause periungual lesions, the researchers note that both patients’ hand lesions were significantly exacerbated by receiving gel manicures.

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: cutaneous lupus erythematosus (CLE), environment, ultraviolet (UV) light

You Might Also Like:
  • Rheumatology Case Report: Bullous Lesions in Patient with Lupus
  • Rare Disease Sheds Light on the Origins of Lupus
  • Cutaneous Lupus Tied to Risk for Coexisting Autoimmune Conditions
  • Atherosclerosis Insights May Shed Light on Lupus

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)